Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein

1 Jan 2022

Abstract excerpt

COVID 19 is a disease caused by a novel coronavirus, SARS-CoV2 originated in China most probably of Bat origin. Multiepitopes vaccine would be useful in eliminating SARS-CoV2 infections as asymptomatic patients are in large numbers. In response to this, we utilized bioinformatic tools to develop an efficient vaccine candidate against SARS-CoV2. The designed vaccine has effective BCR and TCR epitopes screened from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Monoclonal and Polyclonal Antibodies Research
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35002585
DOI: 10.1007/s10989-021-10348-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike ProteinPMID 35002585Read ↗

<i>In Silico</i> design and characterization of multi-epitopes vaccine for SARS-CoV2 from its spike proteinsSemantic proximity Read ↗

Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopesSemantic proximity Read ↗

Multiepitope Subunit Vaccine Design against COVID‐19 Based on the Spike Protein of SARS‐CoV‐2: An In Silico AnalysisSemantic proximity Read ↗

Designing spike protein (S-Protein) based multi-epitope peptide vaccine against SARS COVID-19 by immunoinformaticsSemantic proximity Read ↗

The multi-epitope vaccine prediction to combat Pandemic SARS-CoV-2, an immunoinformatic approachSemantic proximity Read ↗

Genome based Evolutionary study of SARS-CoV-2 towards the Prediction of Epitope Based Chimeric VaccineSemantic proximity Read ↗

Computationally designed multi-epitope vaccine construct targeting the SARS-CoV-2 spike protein elicits robust immune responses in silicoSemantic proximity Read ↗

Epitope based peptide vaccine against SARS-COV2: an immune-informatics approachSemantic proximity Read ↗

Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoproteinSemantic proximity Read ↗

Vaccine design based on 16 epitopes of SARS‐CoV‐2 spike proteinSemantic proximity Read ↗

Immunoinformatic exploration of a multi-epitope-based peptide vaccine candidate targeting emerging variants of SARS-CoV-2Semantic proximity Read ↗

Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.